Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and Docetaxel in Elderly Advanced Gastric Cancer
NCT00209729Phase 2Suspended
- Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Start
- Apr 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, tegafur in gastric cancer (GC), sponsored by Hokkaido Gastrointestinal Cancer Study Group. Started Apr 2005; status: suspended.
02
Drugs
docetaxeltegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00209729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209729.